Aspira Pathlab P/B Ratio

Current P/B Ratio
12.22
High Valuation
Very High - Significant premium, high growth expectations or speculative

Aspira Pathlab P/B ratio. Aspira Pathlab (ASPIRA) P/B ratio is 12.22 (High), book value per share ₹12.00 vs Healthcare average P/B of -0.3 — Very High - Significant premium, high growth expectations or speculative. Browse ASPIRA financial statements for revenue, profit, balance sheet and cash flow data.

Current Valuation Metrics

P/B Ratio 12.22
Current Price ₹131.00
Book Value/Share ₹12.00
Exchange BSE

Book Value Breakdown (2025)

Balance Sheet Components
Total Equity ₹12 Cr
Share Capital ₹10 Cr
Reserves & Surplus ₹-3 Cr
Outstanding Shares 10,000,000
Book Value per Share ₹12.00

Valuation Signal

Signal Overvalued
Historical Avg 5.73
Historical Range 5.52 - 5.95
Percentile 100.0%

Sector Context

Sector Average -0.3
Sector Median 0.39
Sector Rank #11 of 50
Sector Percentile 22.0%

ASPIRA P/B Ratio — Valuation Insights & Book Value Analysis

Aspira Pathlab price-to-book ratio interpretation, valuation status and historical context — current P/B 12.22 (High). For live price, earnings yield and the full fundamental profile, see Aspira Pathlab stock price NSE.

  • Stock appears overvalued with PB of 12.22, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 113.1% above historical average
  • Trading at premium to sector average PB of -0.3

Aspira Pathlab P/B Ratio Historical Trend

ASPIRA annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read Aspira Pathlab dividend policy for the complete payout history and dividend yield track record.

ASPIRA Historical P/B Ratio — Book Value Per Share & Year-End Price

Aspira Pathlab annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2025 5.52 ₹12.0 ₹66.18 ₹12 High
2024 5.95 ₹10.0 ₹59.50 ₹10 High

ASPIRA vs Healthcare Peers — P/B Ratio Comparison

Aspira Pathlab P/B 12.22 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.

Sector Average
-0.3
Sector Median
0.39
Lowest P/B
-7.62
Highest P/B
0.89
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Chennai Meenakshi Multis… CMMHOSP -7.62 ₹27 Low
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -1.2 ₹39 Low
Krebs Biochemicals & Ind… KREBSBIO -0.75 ₹128 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.18 ₹43 Low